Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Earnings Season Could Be Great for Ligand
Yahoo/Zacks.com
Friday, October 24, 2014 - 7:36am
tags:
earnings, Ligand
Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?"
Forbes
Friday, October 24, 2014 - 7:35am
tags:
vaccines, ebola virus, R&D, clinical trials, GSK
Jilted Shire raises guidance again after Q3 earnings jump
Yahoo/Reuters
Friday, October 24, 2014 - 7:32am
tags:
Shire, earnings
AstraZeneca ovarian cancer drug wins European green light
Yahoo/Reuters
Friday, October 24, 2014 - 7:31am
tags:
AstraZeneca, ovarian cancer, Europe, Lynparza, olaparib
In biotech's boardrooms, there are 10 men for every one woman, report says
Fierce Biotech
Thursday, October 23, 2014 - 5:43pm
tags:
biotech
Zimmer Holdings, Inc. Stays Ahead with a Healthy Third Quarter
Motley Fool
Thursday, October 23, 2014 - 5:42pm
tags:
Zimmer, earnings
Will Celgene Become the Next $100 Billion Biotech Stock?
24/7 Wall St
Thursday, October 23, 2014 - 5:34pm
tags:
Celgene
Johnson & Johnson Wins First Pinnacle Hip Implant Trial
Bloomberg
Thursday, October 23, 2014 - 5:28pm
tags:
JNJ, Pinnacle Hip, devices, hip implants
Eli Lilly/Boehringer's Diabetes Drug Under FDA Review
Yahoo/Zacks.com
Thursday, October 23, 2014 - 5:27pm
tags:
Eli Lilly, Boehringer Ingelheim, diabetes, FDA, Jardiance, metformin
Pfizer Announces It Will Buy Back $11 Billion in Shares
Bloomberg
Thursday, October 23, 2014 - 5:26pm
tags:
Pfizer, share repurchase
GSK restructures, as respiratory disappoints
Medical Marketing and Media
Thursday, October 23, 2014 - 9:52am
tags:
GSK
Celgene 3rd-quarter profit jumps 37 pct, tops forecast
Yahoo/Reuters
Thursday, October 23, 2014 - 9:39am
tags:
Celgene, earnings
Alexion Pharma quarterly adj profit beats, raises forecast again
Yahoo/Reuters
Thursday, October 23, 2014 - 9:38am
tags:
Alexion, earnings
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised
Yahoo/Zacks.com
Thursday, October 23, 2014 - 9:37am
tags:
CR Bard, earnings, devices
Boehringer revs up Ofev sales force, support services to rival Roche's Esbriet in IPF
Fierce Pharma Marketing
Thursday, October 23, 2014 - 8:41am
tags:
Boehringer Ingelheim, drug reps, Ofev, Roche, Esbriet, IPF
Novartis Announces Positive Phase-III Results For Secukinumab
Bidness Etc.
Thursday, October 23, 2014 - 8:38am
tags:
Novartis, secukinumab, ankylosing spondylitis
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Yahoo
Thursday, October 23, 2014 - 8:36am
tags:
Takeda, Sucampo, Amitiza
Pfizer Wins SUTENT® Patent Case In Delaware District Court
Yahoo
Thursday, October 23, 2014 - 8:34am
tags:
Pfizer, patents, Sutent, Delaware
Boston Scientific Turnaround Complete, CEO Mahoney Says
Bloomberg
Thursday, October 23, 2014 - 8:11am
tags:
Boston Scientific, devices
Drugmakers may need indemnity for fast-tracked Ebola vaccines
Yahoo/Reuters
Thursday, October 23, 2014 - 8:08am
tags:
ebola virus, FDA, fast track, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.